Showing results (51-60 of 325) with videos related to
Sort By:
Pageof 33
European Journal of Cancer (Oxford, England : 1990)|January 30, 2007
Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer riskStefano Landi, Fabio Bottari, Federica Gemignani, et al.Cancer|January 28, 2012
Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAomeDebora Landi, Federica Gemignani, Barbara Pardini, et al.Journal of Negative Results in Biomedicine|October 26, 2006
Polymorphisms within inflammatory genes and colorectal cancerStefano Landi, Federica Gemignani, Fabio Bottari, et al.Breast Cancer Research and Treatment|February 16, 2010
Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic densityCornelia W Taverne, Martijn Verheus, James D McKay, et al.Scientific Reports|April 18, 2020
Variations in cag pathogenicity island genes of Helicobacter pylori from Latin American groups may influence neoplastic progression to gastric cancerCosmeri Rizzato, Javier Torres, Ofure Obazee, et al.BMC Medical Genomics|April 21, 2021
Susceptibility loci for pancreatic cancer in the Brazilian populationMateus Nóbrega Aoki, Angelika Stein, Jaqueline Carvalho de Oliveira, et al.Oncogene|December 3, 2003
A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNAFederica Gemignani, Victor Moreno, Stefano Landi, et al.International Journal of Cancer|October 16, 2013
The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinomaElena Bonora, Cosmeri Rizzato, Chiara Diquigiovanni, et al.Breast Cancer Research and Treatment|December 8, 2007
Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast densityMartijn Verheus, James D McKay, Rudolf Kaaks, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2021
Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based ChemotherapyHanla A Park, Petra Seibold, Dominic Edelmann, et al.Pageof 33